Research and Markets: Pancreatic Cancer Drugs - Global Strategic Business Report with 57 Profiles of Top Players such as E

DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/560cfc/pancreatic_cancer) has announced the addition of the "Pancreatic Cancer Drugs - Global Strategic Business Report" report to their offering.

This report analyzes the Global market for Pancreatic Cancer Drugs in US$ Million. Annual forecasts are provided for the period 2006 through 2015. The report profiles 57 companies including Abraxis BioScience, Inc., Amgen, Inc, Eli Lilly and Company, F. Hoffmann-La Roche Ltd.., Genentech Inc., and OSI Pharmaceuticals, Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.

Key Topics Covered:

I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS

II. Executive Summary

1. MARKET REVIEW

2. PANCREATIC CANCER - THE STUDY OF A FATAL DISEASE

3. RESEARCH & DEVELOPMENT

4. RECENT INDUSTRY ACTIVITY

5. REGULATORY SUBMISSIONS AND APPROVALS

6. FOCUS ON SELECT PLAYERS

7. GLOBAL MARKET PERSPECTIVE

III. COMPETITIVE LANDSCAPE

Total Companies Profiled: 57 (including Divisions/Subsidiaries - 61)

Region/Country Players

The United States 37

Canada 2

Japan 5

Europe 12

France 1

Germany 5

The United Kingdom 1

Spain 1

Rest of Europe 4

Asia-Pacific (Excluding Japan) 4

Middel East 1

Companies Mentioned:

  • Abraxis BioScience, Inc. (USA)
  • Amgen, Inc. (USA)
  • Eli Lilly and Company (USA)
  • F. Hoffmann-La Roche Ltd. (Switzerland)
  • Genentech Inc. (USA)
  • OSI Pharmaceuticals, Inc. (USA)

For more information visit http://www.researchandmarkets.com/research/560cfc/pancreatic_cancer



CONTACT:

Research and Markets
Laura Wood, Senior Manager
[email protected]
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

KEYWORDS:

INDUSTRY KEYWORDS:   Health  Oncology  Pharmaceutical

MEDIA:

Logo
 Logo

Virtual Clinical Trials Summit

Virtual Clinical Trials Summit: The Premier Educational Event Focused on Decentralized Clinical Trials

In this virtual environment, we will look at current and future trends for ongoing virtual trials, diving into the many ways companies can improve patient engagement and trial behavior to enhance retention with a focus on emerging technology and harmonized data access across the clinical trial system.